<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0872054" disease_type="Disease or Syndrome" abbrv="">latent infection</z:e> transforms B lymphocytes into proliferating lymphoblastoid cell lines (LCLs) </plain></SENT>
<SENT sid="1" pm="."><plain>EBV <z:e sem="disease" ids="C0872054" disease_type="Disease or Syndrome" abbrv="">latent infection</z:e> membrane protein 1 (LMP1) is required for EBV-mediated B lymphocyte transformation, and LMP1-induced NF-κB activation is essential for LCL survival </plain></SENT>
<SENT sid="2" pm="."><plain>To identify a novel inhibitor candidate for LMP1-induced NF-κB activation, crude <z:chebi fb="37" ids="16236,44730">ethanol</z:chebi> extracts of medicinal plants were screened for the potential NF-κB inhibitory activity </plain></SENT>
<SENT sid="3" pm="."><plain>Seventy percent <z:chebi fb="37" ids="16236,44730">ethanol</z:chebi> extract of Chrysanthemum indicum Linne extract (CIE) strongly reduced LMP1-induced NF-κB activation </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, CIE inhibited LMP1-induced IKKα or IKKβ activation </plain></SENT>
<SENT sid="5" pm="."><plain>Interestingly, CIE treatment rapidly reduced LCL viability without exhibiting any adverse effects on the viability of human foreskin fibroblasts (HFF), EBV negative Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines (BL41) or HeLa cells </plain></SENT>
<SENT sid="6" pm="."><plain>Taken together, CIE has potent inhibitory effect on EBV LMP1-induced NF-κB activation and EBV-transformed LCL viability </plain></SENT>
</text></document>